EDN2 and Abnormal retinal morphology: Another target that is decreased with ASC injection is an inflammatory factor, endothelin 2 (Edn2), which promotes central nervous system remyelination [70] and acts as a macrophage attractant [71], both of which are characteristic of retinal disease [72], [73].